pharmaceuticals

  1. A

    India's Healthcare Progress: Government Initiatives and Expanding Access

    Mumbai, February 24 – President Droupadi Murmu stated on Tuesday that the Government of India has taken several important steps over the past decade to ensure that all citizens remain healthy and have access to quality healthcare.The President said that healthy citizens are the foundation of a...
  2. V

    Minister Goyal Emphasizes Key Pillars for India's Economic Future

    Commerce and Industry Minister Piyush Goyal stated today that zero defects, zero impact, and equal opportunities for all are the key pillars of the country's growth story. Speaking at the plenary session of the National Quality Conclave 2026 virtually in New Delhi, Mr. Goyal said that these...
  3. P

    Ranluspec Approval: Lupin's Biosimilar for Eye Conditions Gains EU Clearance

    New Delhi, February 23 Drug maker Lupin announced on Monday that it has received approval from the European Commission for its biosimilar for the treatment of various eye conditions.The company has received approval for Ranluspec (ranibizumab), following the recent positive opinion from the...
  4. K

    Expanding Horizons: Torrent Group's Entry into the Diagnostics Sector

    New Delhi, February 23 Torrent Group announced its entry into the diagnostics sector on Monday.The company commenced operations of the country's largest National Reference Laboratory in Navi Mumbai, marking the group's expansion into diagnostic services through a reference-led model.The...
  5. S

    Trump Announces Temporary Import Surcharge, India Studies Impact

    Washington/New Delhi, Feb 21 India will face a reduced tariff of 10 per cent from February 24 for 150 days, after US President Donald Trump announced a new global levy on imports into America following a Supreme Court verdict against his earlier sweeping tariffs.The Indian government is...
  6. A

    Trade Shift: US Tariffs Impact India-US Bilateral Trade

    New Delhi, February 21 Reducing the US's reciprocal tariff on India from 25 per cent to 10 per cent will significantly improve the competitiveness of labor-intensive sectors in the US, such as pharmaceuticals, electronics, engineering, textiles, and jewelry.This is a major setback for US...
  7. A

    Zydus Launches Biosimilar for Diabetes-Related Visual Impairment

    New Delhi, February 19 Zydus Lifesciences announced on Thursday that it has launched its first biosimilar, developed indigenously, for the treatment of visual impairment.Anyra, the country's first biosimilar of Aflibercept 2 mg, is indicated for the treatment of visual impairment caused by...
  8. A

    Nadda Meets with Brazilian Health Minister to Discuss Healthcare Cooperation

    Union Health Minister J P Nadda met his Brazilian counterpart, Alexandre Padilha, in New Delhi on the sidelines of the India-AI Impact Summit. They had a productive discussion on making healthcare accessible and affordable for everyone. Both sides also emphasized the need for closer and stronger...
  9. N

    US Panel Highlights Persistent India-China Strategic Competition

    Washington, February 18 – China’s expanding military presence, economic leverage, and technological dominance are intensifying India’s strategic concerns, top American and Indian experts told a U.S. congressional commission on Tuesday, warning that New Delhi’s rivalry with Beijing remains...
  10. N

    Government Launches Frameworks for Responsible AI in Indian Healthcare

    New Delhi, February 17 Interoperable systems have been enabled across platforms, and large-scale, consent-based health-data frameworks are being developed to empower citizens while ensuring data privacy and security, Union Health Minister J P Nadda said on Tuesday.He made the remarks while...
  11. B

    Government Launches SAHI Framework to Drive AI in Indian Healthcare

    New Delhi, February 17 With the growing digital public infrastructure and health data ecosystems, India is now in a better position to meaningfully harness artificial intelligence (AI) to the benefit of doctors, healthcare workers, and the 1.4 billion citizens, Union Health Minister JP Nadda...
  12. B

    BioAsia 2026 Highlights Hyderabad's Rising Life Sciences Hub

    Hyderabad, February 17 – Telangana Chief Minister A. Revanth Reddy stated on Tuesday that Hyderabad has the potential to evolve from a global vaccine capital to a global life sciences capital.While inaugurating BioAsia 2026 along with IT & Industries Minister D. Sridhar Babu, he emphasized...
  13. N

    International Summit Highlights India's Growing Life Sciences Sector

    Telangana Chief Minister A. Revanth Reddy will inaugurate the 23rd edition of BioAsia 2026 international summit today. The two-day global conference will be held at the Hyderabad International Convention Centre (HICC). This year's summit is themed "TechBio Unleashed – AI, Automation, and the...
  14. A

    Leveraging Biodiversity: DST's Biotech Initiative for J&K

    JAMMU, February 15: The Department of Science and Technology (DST) is developing a comprehensive Biotechnology Policy and roadmap for Jammu & Kashmir to utilize its rich biodiversity and scientific potential.Commissioner Secretary Shahid Iqbal Choudhary chaired a review meeting where officials...
  15. A

    Generic Medicines Accessible Through New Healthcare Hub

    Bhopal, February 15 – The Jan Aushadhi Kendra, established in the Rajgarh district of Madhya Pradesh, has become a new hub of activity, as patients and their relatives are flocking to the medical store to purchase highly subsidized medicines, which elsewhere are a significant financial burden...
  16. I

    Delhi Health Dept Takes Action Against Pharmaceutical Firms

    New Delhi, February 14 The Delhi government's drugs control department found violations of rules during a raid at 10 pharmaceutical firms in the Nangloi area, according to a statement released on Saturday.As part of a special enforcement drive under the direction of Health Minister Pankaj...
  17. S

    Pharmaceutical Company Akums Reports Revenue Growth

    New Delhi, February 13 Akums Drugs & Pharmaceuticals reported a 29.5 per cent increase in consolidated net profit to Rs 86 crore for the third quarter ended December 2025, on Friday.The company earned a net profit of Rs 66 crore in the October-December quarter of the previous fiscal year.Its...
  18. I

    Torrent Pharmaceuticals Revenue Up, Driven by Branded Business

    New Delhi, February 13 Torrent Pharmaceuticals Ltd on Friday reported a 26.24 per cent increase in consolidated net profit to Rs 635 crore for the December quarter of fiscal 2025-26, driven by strong performance of its branded business.The company had posted a net profit of Rs 503 crore for...
  19. A

    Pharmaceutical Growth Drives Zydus Lifesciences' Net Profit Increase

    New Delhi, February 9 Zydus Lifesciences Ltd on Monday reported a 1.81 per cent increase in consolidated net profit at Rs 1,042.1 crore for the quarter ended December 31, 2025.The company had posted a consolidated net profit of Rs 1,023.5 crore in the corresponding quarter of the previous...
Back
Top